Institution statistics

CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES - France 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:68
Networking Rank (Reputation):900-1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:800-900
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:400-500
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 18
As coordinator: 0
As participant: 18
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 13.137.396 2.023.469 1
2018 0 12.591.211 1.368.522 2
2017 0 5.555.836 375.125 1
2015 0 5.425.113 345.281 1
2013 0 5.996.971 461.305 1
2012 0 11.947.742 848.512 3
2010 0 22.771.541 777.892 2
2008 0 3.316.415 276.368 1
2007 0 12.500.000 304.878 1
2006 0 24.185.102 786.782 2
2005 0 9.781.150 376.198 1
2004 0 6.000.000 33.898 1
2002 0 2.628.567 328.571 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE10
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS8
CHARITE UNIVERSITAETSMEDIZIN BERLIN8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR5
UNIVERSITY COLLEGE LONDON5
KING'S COLLEGE LONDON4
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
INSTITUT CATALA DE LA SALUT3
KAROLINSKA INSTITUTE3
KLINIKUM DER UNIVERSITAET REGENSBURG3
LEIDEN UNIVERSITY MEDICAL CENTER3
MEDIZINISCHE HOCHSCHULE HANNOVER3
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
ETABLISSEMENT FRANCAIS DU SANG2
HOSPICES CANTONAUX CHUV2
HOSPICES CIVILS DE LYON2
HOSPITAL UNIVERSITARIO LA PAZ2
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY2
MEDIZINISCHE UNIVERSITAET INNSBRUCK2
MILTENYI BIOTEC2
NATIONAL UNIVERSITY OF IRELAND GALWAY2
STICHTING KATHOLIEKE UNIVERSITEIT MORE PARTICULARLY RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE2
THE HEBREW UNIVERSITY OF JERUSALEM2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA2
UNIVERSITA DEGLI STUDI DI PADOVA2
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA2
UNIVERSITAET ULM2
UNIVERSITE DE LIEGE2
UNIVERSITE LIBRE DE BRUXELLES2
UNIVERSITY OF COPENHAGEN2
VRIJE UNIVERSITEIT BRUSSEL2
AARHUS UNIVERSITY HOSPITAL1
ABTEILUNG KLINISCHE IMMUNOLOGIE MEDIZINISCHE HOCHSCHULE HANNOVER1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AKADEMIA MEDYCZNA W WARSZAWIE1
ALCIMED1
ANKARA UNIVERSITY1
ANTWERP UNIVERSITY HOSPITAL1
ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA1
ASSOCIATION POUR LA RECHERCHE SUR LES TRANSPLANTATIONS MEDULLAIRES1
ASTELLAS PHARMA EUROPE B V1
AVANTEA1
AZIENDA OSPEDALIERA DI PADOVA1
AZIENDA OSPEDALIERA OSPEDALE SAN MARTINO1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI1
AZIENDA OSPEDALIERAOSPEDALI RIUNITI DI BERGAMO1
AZIENDA OSPEDALIEROUNIVERSITARIA ANNA MEYER1
BAYERISCHE JULIUS MAXIMILIANS UNIVERSITAET WUERZBURG1
BELARUSIAN RESAERCH CENTER FOR PEDIATRIC ONCOLOGY AND HEMATOLOGY OF MINISTRY OF HEALTH OF BELARUS1
BG KLINIKUM BERGMANNSTROST HALLE GGMBH1
BIOALLIANCE PHARMA1
BIOMATLANTE SAS1
BIOMAX INFORMATICS1
BIOMEDICAL SCIENCES RESEARCH CENTRE "ALEXANDER FLEMING"1
BIORELIANCE1
BLASTICON BIOTECHNOLOGISCHE FORSCHUNG1
BRISTOL MYERS SQUIBB INTERNATIONAL CORPORATION1
CARDINAL SYSTEMS1
CEINGE BIOTECNOLOGIE AVANZATE SCA RL1
CELL THERAPY CATAPULT LIMITED1
CELLGENIX TECHNOLOGIE TRANSFER1
CELLOGIC1
CELLTREND GESELLSCHAFT MIT BESCHRANKTER HAFTUNG1
CENTRAL MANCHESTER AND MANCHESTER CHILDREN'S UNIVERSITY HOSPITALS NHS TRUST1
CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS1
CENTRE HOSPITALIER UNIVERSITAIRE DE CAEN1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE HOTELDIEU SAINT JAQUES1
CENTRE HOSPITALIER UNIVERSITAIRE SAINT PIERRE1
CENTRE HOSPITALIER UNIVERSITAIRE SWISS HIV COHORT STUDY1
CENTRO HOSPITALAR DE COIMBRA EPE1
CENTRO NACIONAL DE TRASPLANTES Y MEDICINA REGENERATIVA ONT1
CERNER FRANCE1
CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
CHILDREN'S CANCER RESEARCH INSTITUTE'1
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CITOSPIN SL1
CLEAN CELLS1
CLINIT1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSORZIO INTERUNIVERSITARIO PER LA GESTIONE DEL CENTRO DI CALCOLO ELETTRONICO DELL'ITALIA NORD ORIENTALE1
CUREVAC THE RNA PEOPLE1
DEUTSCHE LEUKAMIE UND LYMPHOMHILFE EV1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EBERHARDKARLS UNIVERSITAT TUBINGEN1
EBERHARDKARLSUNIVERSITAET TUEBINGEN1
ECBIO INVESTIGACAO E DESENVOLVIMENTO EM BIOTECNOLOGIA S A1
ECOLE NORMALE SUPERIEURE DE CACHAN1
EFFIMUNE SAS1
EGYESITETT SZENT ISTVAN ES SZENT LASZLO KORHAZRENDELO INTEZET1
ELECTRO SCIENTIFIC INDUSTRIES EUROPE1
Constancy:

Total number of partners:459

Partner loyalty:
Frequent Partner: (> 2 projects): 70
Rare Partner: 389

Frequent / Rare Partner Ratio: 0.18

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES11
RTD HORIZONTAL TOPICS5
SOCIAL AND ECONOMIC CONCERNS1
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials RESHAPEparticipant13.137.3969
2018-01-01Personalised maxillofacial bone regeneration MAXIBONEparticipant5.949.66512
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54612
2017-01-01REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy RESPINEparticipant5.555.83615
2015-05-01A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease BETA3_LVHparticipant5.425.11312
2013-09-01Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINKparticipant5.996.97113
2012-11-01Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation BIO-DRIMparticipant5.989.00017
2012-11-01Systems prediction of Chronic Lung Allograft Dysfunction SYSCLADparticipant2.999.1529
2012-01-01Tolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway TRIADparticipant2.959.5907
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116
2010-01-01Regenerating Bone defects using New biomedical Engineering approaches REBORNEparticipant11.935.34024
2008-11-01Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukemia in children LOULLA&PHILLAparticipant3.316.41512
2007-02-01European AIDS treatment Network NEATparticipant12.500.00041
2006-04-01European network for the advancement of clinical gene transfer and therapy CLINIGENEparticipant12.000.00043
2006-03-01Cancer Immunology and Immunotherapy CANCERIMMUNOTHERAPYparticipant12.185.10224
2005-03-01Reprogramming the immune System for the Establishment of Tolerance RISETparticipant9.781.15026
2004-01-01Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe EUROPEAN LEUKEMIANETparticipant6.000.000177
2002-01-01Targeting heme-oxygenase-1 or downstream processes : a new therapeutic approach for treatment of inflammation. HO-1participant2.628.5678

Alias institution names:
  • CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum